Validation of a 4-miRNA prognosticator allowing for improved risk stratification of glioblastoma patients in combination with MGMT promoter methylation status.
Strahlenther. Onkol.195, S63-S63 (2019)
Open Access Green as soon as Postprint is submitted to ZB.